Picture of GemVax & KAEL Co logo

082270 GemVax & KAEL Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
TechnologySpeculativeMid CapMomentum Trap

Annual cashflow statement for GemVax & KAEL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,63512,058-19,604-27,177-87,219
Depreciation
Amortisation
Non-Cash Items4,874-13,58716,71121,46155,766
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital5,727-4,252-3,1025,291-1,254
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities13,955-3,467-2,9553,566-28,369
Capital Expenditures-10,374-6,874-9,090-8,461-3,489
Purchase of Fixed Assets
Other Investing Cash Flow Items-10,948-21,19515,582-2,053-46,555
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-21,322-28,0696,492-10,514-50,044
Financing Cash Flow Items95
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3,021-661-5,9797,73965,412
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,580-32,054-2,919720-12,944